Absolute levels of risk are needed to make informed decisions for patientsRenal adverse effects of proton pump inhibitors (PPIs) were described in your research briefing ‘Proton pump inhibitors linked with chronic kidney disease’ ( Clinical Pharmacist 2015;7:217). Simply telling us that there was a 10% or 50% increase among …
Proton pump inhibitors linked with chronic kidney disease A growing body of evidence has linked proton pump inhibitors with acute kidney injury and now new research has also found links with chronic kidney disease.…
New drug for diabetic kidney disease has promising results In an international study, finerenone was effective at reducing protein in the urine without the rate of side effects of other drugs in the class.…
Specialist roles in hospital pharmacy Pharmacy professionals have the opportunity to specialise in a variety of clinical areas. Eamonn McArdle explores the possibilities.…
Scotland brings in medicine card to avoid kidney injury after dehydration Pocket-sized patient information cards that warn patients to temporarily stop taking specific medicines if they have a dehydrating illness are being introduced across Scotland.…
Impaired kidney function may not justify avoidance of nitrofurantoin Advice not to use nitrofurantoin to treat patients with urinary tract infections who have impaired kidney function may be unfounded, research suggests.…
Dialysis: principles and treatment options How to choose between haemodialysis and peritoneal dialysis when starting renal replacement therapy.…
Dialysis: management How to identify and manage potential complications and challenges presented by haemodialysis and peritoneal dialysis.…
EMA recommends treatment for rare kidney condition The European Medicines Agency has recommended the approval of tolvaptan for the treatment of a rare inherited disease, autosomal dominant polycystic kidney disease.…
Paracetamol use linked with cardiovascular risk and other adverse events Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.…
